Replies to post #10041 on Synaptogenix Inc (SNPX)

[Alzy B]

Right on, Antti!

[Theburg]

I can’t imagine that BP would not try to quickly buyout NTRP if we get good results in a few months. It wouldn’t just be good results, but good results using a different approach, not to mention on the most difficult moderate to severe AD patients. FOMO will cause BP to act fast so that their competitors won’t get the drug. I don’t think NTRP will get a chance to run a Ph3.